Home

Syncom Formulations (india) PE Ratio

Image

Syncom Formulations (India) Ltd

NSE: SYNCOMFORMUL

PE

35.8

Last updated on: May 10, 2025

Key Highlights

  • The P/E Ratio of Syncom Formulations (India) Ltd is 35.8 as of 10 May 15:30 PM .
  • The P/E Ratio of Syncom Formulations (India) Ltd changed from 46.2 on March 2022 to 41.4 on March 2024 . This represents a CAGR of -3.59% over 3 years.
  • The Latest Trading Price of Syncom Formulations (India) Ltd is ₹ 15.05 as of 09 May 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 40.1 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.1. The PE Ratio of Pharmaceuticals industry is 40.1. The PE Ratio of Retail industry is 139.8. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Syncom Formulations (India) Ltd

No data available

Company Fundamentals for Syncom Formulations (India) Ltd

Image

Syncom Formulations (India) Ltd

NSE: SYNCOMFORMUL

Share Price

₹ 15.05

-0.42 (-2.71%)

stock direction

Last updated on: May 09, 2025

Market Price of Syncom Formulations (India) Ltd

1M

1Y

3Y

5Y

Monitoring Syncom Formulations (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 May 202515.05
08 May 202515.47
07 May 202515.79
06 May 202515.57
05 May 202516.46
02 May 202516.22
30 Apr 202516.32
29 Apr 202516.8
28 Apr 202516.88
25 Apr 202517.04

SWOT Analysis Of Syncom Formulations (India) Ltd

Strength

3

che

Weakness

3

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Syncom Formulations (India) Ltd

Asset Value vs Market Value of Syncom Formulations (India) Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Syncom Formulations (India) Ltd1414
Sun Pharmaceutical Industries Ltd418648
Divis Laboratories Ltd159310
Cipla Ltd119410
Torrent Pharmaceuticals Ltd106184
Mankind Pharma Ltd99570

PE Ratio of Syncom Formulations (India) Ltd Explained

1414

Market cap

39

Earnings

35.8X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Syncom Formulations (India) Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Syncom Formulations (India) Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Syncom Formulations (India) Ltd

No data available

* All values are in %

About Syncom Formulations (India) Ltd

  • Incorporated as a private limited company in 1988, Syncom Formulations (India) Limited was converted into a public limited company in Jun.'92.
  • The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency.
  • Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur, Madhya Pradesh. Established in 1988, Syncom plant is geared up with latest production machineries and maintains high quality standards.
  • Currently, the Company manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers. The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations.

Syncom Formulations (India) Ltd News Hub

Nifty slips below 24,200 level; Nifty bank shares buck trend; HDFC Bank drops 2.93%

The main equity indices traded with significant losses in mid-afternoon trade. The Nifty dropped bel

Read more

13 Aug 24

Syncom Formulations gains after Q1 PAT rises over 73% YoY

Net sales rose by 45.8% year-over-year (YoY) during the quarter to Rs 87.26 crore. Total expenditure

Read more

13 Aug 24

Syncom Formulations (India) consolidated net profit rises 73.41% in the June 2024 quarter

Net profit of Syncom Formulations (India) rose 73.41% to Rs 7.63 crore in the quarter ended June 202

Read more

12 Aug 24

Syncom Formulations (India) announces board meeting date

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 12 Augus

Read more

06 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Syncom Formulations (India) Ltd

What is the current PE Ratio of Syncom Formulations (India) Ltd?

The Current PE Ratio of Syncom Formulations (India) Ltd is 35.83 as on 10 May 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.1 as on 10 May 2025.

What was the PE Ratio of Syncom Formulations (India) Ltd last year?

The PE Ratio of Syncom Formulations (India) Ltd was 28.1 last year, now the PE ratio is 35.83, showing a year-on-year growth of 27.5%.

What does the PE Ratio of Syncom Formulations (India) Ltd indicate about its stock?

The PE Ratio of Syncom Formulations (India) Ltd is 35.83. This ratio indicates that investors are willing to pay 35.83 times the earnings per share for each share of Syncom Formulations (India) Ltd.

What is the PE Ratio Growth of Syncom Formulations (India) Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Syncom Formulations (India) Ltd grew by 27.5% whereas, the EPS ratio grew by -12.5.

How does the PE ratio of Syncom Formulations (India) Ltd compare to industry peers?

The PE ratio of Syncom Formulations (India) Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Syncom Formulations (India) Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Syncom Formulations (India) Ltd PE Ratio.

What factors influence the PE ratio of Syncom Formulations (India) Ltd PE Ratio?

The PE ratio of Syncom Formulations (India) Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Syncom Formulations (India) Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Syncom Formulations (India) Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Syncom Formulations (India) Ltd PE Ratio?

You can check the latest PE ratio of Syncom Formulations (India) Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Syncom Formulations (India) Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Syncom Formulations (India) Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Syncom Formulations (India) Ltd PE Ratio predict future stock performance?

While the Syncom Formulations (India) Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions